CAMELI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 2.817
AS - Asia 1.855
EU - Europa 1.340
SA - Sud America 509
AF - Africa 72
OC - Oceania 8
Totale 6.601
Nazione #
US - Stati Uniti d'America 2.670
SG - Singapore 689
RU - Federazione Russa 525
CN - Cina 488
BR - Brasile 382
VN - Vietnam 309
IT - Italia 262
GB - Regno Unito 126
HK - Hong Kong 117
DE - Germania 93
CA - Canada 92
FR - Francia 73
IN - India 57
FI - Finlandia 52
AR - Argentina 47
MX - Messico 46
PL - Polonia 36
NL - Olanda 34
BD - Bangladesh 32
ID - Indonesia 31
ZA - Sudafrica 31
TR - Turchia 27
SE - Svezia 26
UA - Ucraina 26
EC - Ecuador 22
ES - Italia 19
CO - Colombia 18
JP - Giappone 18
AT - Austria 17
IE - Irlanda 13
IQ - Iraq 13
PK - Pakistan 13
CL - Cile 12
IL - Israele 12
MA - Marocco 12
VE - Venezuela 12
LT - Lituania 10
TN - Tunisia 9
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
KE - Kenya 6
MY - Malesia 6
AU - Australia 5
BO - Bolivia 5
HU - Ungheria 4
PH - Filippine 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
GR - Grecia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GG - Guernsey 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PG - Papua Nuova Guinea 1
SR - Suriname 1
TG - Togo 1
TW - Taiwan 1
Totale 6.601
Città #
Dallas 1.122
Singapore 364
San Jose 241
Ashburn 238
Beijing 190
Hong Kong 115
Moscow 105
Ho Chi Minh City 103
Los Angeles 91
Hanoi 75
New York 67
Chandler 61
São Paulo 47
Santa Clara 44
Lauterbourg 38
Orem 38
The Dalles 35
Montreal 32
Munich 32
Helsinki 30
Warsaw 30
Hefei 29
San Mateo 26
Council Bluffs 25
London 25
Milan 25
Boardman 24
Johannesburg 24
Frankfurt am Main 23
Mexico City 23
Ottawa 23
Amsterdam 21
Seattle 21
Denver 20
Fairfield 20
Pisa 19
Buffalo 18
Chennai 18
Tokyo 18
Rome 17
Stockholm 17
Beauharnois 16
Cambridge 16
Brooklyn 15
Phoenix 15
New Delhi 14
Poplar 14
Atlanta 13
Dublin 13
Houston 13
Rio de Janeiro 13
Da Nang 12
Manchester 12
Paris 11
Portsmouth 11
Querétaro 11
Toronto 11
Turku 11
Assago 10
Bologna 10
Florence 10
Istanbul 10
Lawrence 10
Nuremberg 10
Stevenage 10
Ankara 9
Boston 9
Chicago 9
Dong Ket 9
Lappeenranta 9
Quito 9
Washington 9
Woodbridge 9
Guayaquil 8
Leeds 8
Medellín 8
Mumbai 8
Shanghai 8
Tel Aviv 8
Thái Bình 8
Brasília 7
Haiphong 7
Naples 7
San Francisco 7
Vienna 7
Wilmington 7
Belo Horizonte 6
Biên Hòa 6
Bắc Ninh 6
Campinas 6
City of London 6
Curitiba 6
Falls Church 6
Ha Long 6
Malang 6
Nairobi 6
Porto Alegre 6
Tashkent 6
Düsseldorf 5
Jacksonville 5
Totale 4.077
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 698
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 273
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 260
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 258
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 243
Eligibility for vericiguat in a real‐world, contemporary heart failure population 238
Cardiogenic shock and acute kidney injury: the rule rather than the exception 222
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 218
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 214
Perspectives in noninvasive imaging for chronic coronary syndromes 213
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 204
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 200
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 200
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 199
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 199
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub-analysis of DISCOVER-ARNI 199
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 198
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 195
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 193
Sex-related differences in ventricular remodeling after myocardial infarction 189
Arterial hypertension and atrial fibrillation: Standard and advanced echocardiography from diagnosis to prognostication 186
The diseased Tricuspid valve. Non invasive imaging of Tricuspid valve – Ultrasounds Trans-Thoracic Echocardiography (TTE) and Trans-Esophageal Echocardiography (TTE). 183
The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study 181
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 178
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 178
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 172
Resistant hypertension: An overview 161
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 158
Speckle tracking echocardiography in heart failure development and progression in patients with apneas 147
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 97
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 50
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 46
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 46
Linda Pagura 1, Aldostefano Porcari 2, Matteo Cameli 3, Elena Biagini 4, Marco Canepa 5, Lia Crotti 6, Massimo Imazio 7, Cinzia Forleo 8, Rita Pavasini 9, Giuseppe Limongelli 10, Stefano Perlini 11, Marco Metra 12, Giuseppe Boriani 13, Michele Emdin 14, Gianfranco Sinagra 2, Marco Merlo 15; ACTIVE study group 39
Totale 6.635
Categoria #
all - tutte 30.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 5 14 16
2021/2022135 13 15 2 7 2 8 11 27 8 22 9 11
2022/2023140 11 28 3 22 12 17 2 10 17 5 10 3
2023/2024209 11 3 29 11 10 26 19 4 7 16 9 64
2024/20251.308 27 27 99 26 76 72 194 306 113 50 187 131
2025/20264.753 229 652 1.111 630 538 331 433 256 328 245 0 0
Totale 6.635